Drug Pipeline

ALXN1850 Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
3
Active Studies
0
Recruiting
3
Phase 3
1
Top Sponsors
Active Studies by Phase
Phase 3
3
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT06079372 Phase 3 Study of ALXN1850 in Pediatric Participants With HPP Previously Treated With… Hypophosphatasia Active, Not Recruiting
NCT06079281 Phase 3 Study of ALXN1850 Versus Placebo in Adolescent and Adult Participants With HPP… Hypophosphatasia Active, Not Recruiting
NCT06079359 Phase 3 Study of ALXN1850 in Treatment-Naïve Pediatric Participants With HPP Hypophosphatasia Active, Not Recruiting
Sponsors Running ALXN1850 Trials
Alexion Pharmaceuticals, Inc. (3)
Get alerts when ALXN1850 trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free